¹û¶³Ó°Ôº

XClose

Translational Research Office (TRO)

Home
Menu

Resources

Reports and informative resources provided by the TRO.

To acknowledge 10 years of operation in 2021, weÌýput together a review of our achievements to celebrate all things TRO - from funding successes, drug discoveries and project progressions from preclinical to clinical, to spin out contributions and the development of long-term industry relationships.Ìý

We also highlight how our vision and values in the areas of Research, Innovation and Education contribute to wider ¹û¶³Ó°Ôº goals and how we will continue to build on an increasingly vibrant translational culture over the next 10 years. Ìý

Jane Kinghorn, Director at ¹û¶³Ó°Ôº Translational Research Office and Nick McNally, Managing Director Research ¹û¶³Ó°Ôº/¹û¶³Ó°ÔºH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.Ìý

Jane Kinghorn, ¹û¶³Ó°Ôº TRO DirectorÌýand Anne Lane, CEO at ¹û¶³Ó°Ôº Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at ¹û¶³Ó°Ôº and their partner hospitals.

Impact Early Career Researcher article cover

Translational education and training for early career researchers

In this interview, Colby Benari, Head of the Academic Careers Office (ACO) at ¹û¶³Ó°Ôº, discusses the role and impact of the ¹û¶³Ó°Ôº ACO and highlights new translational training opportunities for Early Career Researchers.Ìý

Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office)Ìýat ¹û¶³Ó°Ôº, explain the value of drug discovery in academia in bridging the "Valley of Death".

impact cover - the innovation game

The innovation game

Professor David Lomas discusses the Therapeutic Innovation Networks (TINs), which are facilitating and accelerating enterprise at ¹û¶³Ó°Ôº (¹û¶³Ó°Ôº),

Jane Kinghorn, along with Marta Ribeiro, Felipe Fouto, and Colby Benari from ¹û¶³Ó°Ôº, argue that the ability to listen and learn makes ¹û¶³Ó°Ôº a global partner of choice for health research and innovation.Ìý

impact article - translating novel science to patient benefit

Translating novel science to patient benefit

Dr Jane Kinghorn discusses how ¹û¶³Ó°Ôº (¹û¶³Ó°Ôº)’s Translational Research Office (TRO) is working to encourage, facilitate and contribute to the translation of ¹û¶³Ó°Ôºâ€™s and its partner hospitals’ research.

cell, gene and regenerative medicine at ¹û¶³Ó°Ôº and NHS partner trusts

Cell, Gene and Regenerative Therapies at ¹û¶³Ó°Ôº and NHS Partner Trusts

¹û¶³Ó°Ôº in partnership with our three NIHR BRCs at ¹û¶³Ó°Ôº Hospital (¹û¶³Ó°ÔºH), Great Ormond Street Hospital for Children (GOSH) and Moorfields Eye Hospital (MEH) are world leaders in the development and delivery to patients of novel cell, gene and regenerative therapies.Ìý

¹û¶³Ó°Ôº supporting Healthcare Leadership and Innovation capacity building in Africa

¹û¶³Ó°Ôº supporting Healthcare Leadership and Innovation capacity building in Africa

In late 2018, ¹û¶³Ó°Ôºâ€™s Academic Careers Office (ACO) and Translational Research Office (TRO) along with ¹û¶³Ó°Ôº partner the Africa Health Research Institute (AHRI), were successful in applying for a UKRI Global Challenge Research Fund Impact Acceleration Award (GCRF IAA).ÌýThe ACO and TRO organised two events in South Africa open to participants from across the African continent.